Belimumab-induced remission in refractory lupus mesenteric vasculitis: a case report with 49-month follow-up
This case demonstrates belimumab's efficacy in achieving the longest documented remission (49 months) in refractory LMV, highlighting its potential as a first-line biologic for steroid-dependent gastrointestinal vasculitis.
Authors
- Yinshan Zang (ORCID: https://orcid.org/0000-0001-6812-8930)
- Yan Xu (ORCID: https://orcid.org/0000-0002-8883-0257)
- Wen-Jia Gao
- Qi-feng Zang
Institutions
- Bengbu Medical College (CN)
- Jiangsu Province Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-03-04
- DOI
- https://doi.org/10.3389/fimmu.2026.1687299
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00